Product News – Spring Edition Product News – Spring Edition
IPT highlights some of the most recent exciting advancements in pharmaceutical manufacturing

DNA Script announced it has signed distribution agreements with Gencell, Bio-Medical Science Co and BioStream Co, expanding global access to the company’s SYNTAX platform for decentralised, in-house and on-demand oligonucleotide production. Under the agreements, Gencell will distribute SYNTAX across Latin America, Bio-Medical Science will cover South Korea and BioStream will support customers in Japan. This expansion supports DNA Script’s strategy to broaden global adoption of SYNTAX and enable researchers located far from major oligonucleotide production hubs in Europe and the US to access DNA more quickly and reliably. Each distributor is an established life and health sciences company with strong regional networks, enabling local access to DNA synthesis capabilities without reliance on overseas manufacturing. DNA Script’s automated, benchtop SYNTAX platform addresses challenges by enabling researchers to synthesise ssDNA oligonucleotides directly within the lab in only few hours, shifting the model from centralised supply chains to local DNA production and ensuring geography does not determine scientific speed.